✦ LIBER ✦

Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

✍ Scribed by Pilar Garrido, Javier de Castro, Ángel Concha, Enriqueta Felip, Dolores Isla, Fernando López-Ríos, Luis Paz-Ares, José Ramírez, Julián Sanz, José Javier Gómez

Book ID: 113094844
Publisher: Springer Milan
Year: 2012
Tongue: Spanish
Weight: 483 KB
Volume: 14
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-012-0806-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guidelines for biomarker testing in colo

Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

✍ Pilar García-Alfonso, Ramón Salazar, Jesús García-Foncillas, Eva Musulén, Rocío 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 289 KB

Guidelines for HER2 testing in breast ca

Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

✍ Joan Albanell; Xavier Andreu; María José Calasanz; Ángel Concha; José María Coro 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 626 KB

Consensus of the Spanish Society of Medi

Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) forHER2testing in gastric carcinoma

✍ Carlos Gómez-Martín; Ángel Concha; José María Corominas; Tomás García-Caballero; 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 588 KB

Consensus conference on palliative treat

Consensus conference on palliative treatment of stage IV non-small cell lung cancer: Consensus meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis

✍ V.C.G Tjan-Heijnen; H.J.M Groen; F.M.N.H Schramel; G Stoter 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Pemetrexed Versus Pemetrexed and Carbopl

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

✍ Ardizzoni, A.; Tiseo, M.; Boni, L.; Vincent, A. D.; Passalacqua, R.; Buti, S.; A 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 200 KB